Markets
markets

Tempus AI rises on better-than-expected sales numbers

Cancer diagnostics company and retail shareholder favorite Tempus AI surged early Monday after issuing some fresh, though preliminary, financials ahead of an appearance at an investor conference today.

The Chicago-based company reported better-than-expected Q4 sales numbers of roughly $367 million — Wall Street had expected about $361 million — as well as a diagnostics revenue that more than doubled to $266 million. It also posted an updated corporate presentation on its website ahead of an appearance at the JPMorgan Healthcare Conference that’s expected at 4:30 p.m. ET today.

The company noted that it hasn’t completed its official full-year 2025 or Q4 financial statements yet, which it typically files in February.

Wall Street expects Tempus to lose money through 2027. But the stock has been ripping, rising 75% last year, and through Monday’s open has tacked on another 24% in 2026.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.